Abstract
Introduction
γ-Hydroxybutyricacid (GHB) has been used as a prescription medicine for the treatment of narcolepsy and alcohol dependence. Quantification of GHB in biological fluids from GHB intoxication cases is not clear for verifying exposure to GHB due to the presence of endogenous GHB, which is rapidly metabolized, via GABA and/or succinic semialdehyde, to succinic acid which enters the tricarboxylic acid (TCA) cycle. However, their exact mechanism was not fully understood.
Objectives
In this study, comprehensive organic acid (OA) profiling analysis including OAs related to TCA cycle, GHB and 2-hydroxyglutaric acid (2-HG) as a prominent metabolite was performed by gas chromatography–mass spectrometry (GC–MS) in scan mode to understand the biochemical events and monitor altered OA metabolism in rat urine samples following treatment with GHB.
Methods
OA profiling as methoxime/tert-butyldimethylsilyl derivatives by GC–MS combined with star pattern analyses were performed in rat urine samples following intraperitoneal administration of GHB once per day for one (single) and ten consecutive days (multiple).
Results
In the GC–MS with selected ion monitoring (SIM) mode, GHB was massively increased in urine samples of treated groups, while it showed as trace levels in control group. In all groups, α-ketoglutaric acid was most abundant, followed by citric, and isocitric acids among 18 quantified OAs. In analysis of variance (ANOVA) test for three groups, 15 OAs including 2-HG as a prominent metabolite of GHB were significantly different (p < 0.05). All the 18 OAs in the single administration group were increased compared with the multiple administration groups, which indicates that the OA metabolic disturbance following single administration is much larger than that by multiple administration. Their values were normalized to the corresponding mean values of the control group and then plotted into star symbol patterns, which were characteristic and readily distinguishable for each group from distorted octadecagonal shapes. In particular, 2-HG was 920 and 810% higher than that of control group in single and multiple administration groups, respectively. The elevation of GHB and 2-HG is explained by administration of GHB. In principle component analysis, isocitric, citric and cis-aconitic acids were monitored as contributing factors for discrimination of the three groups, which may explain for altered metabolism of OAs related with TCA cycle by administration and intoxication of GHB.
Conclusions
Altered organic acid metabolism following treatment with γ-hydroxybutyric acid.
Similar content being viewed by others
References
Brailsford, A. D., Cowan, D. A., & Kicman, A. T. (2010). Urinary γ-hydroxybutyrate concen-trations in 1126 female subjects. Journal of Analytical Toxicology, 34, 555–561.
De Paoli, G., Pounder, D. J., & Walker, K. M. (2011). Endogenous γ-hydroxybutyric acid con-centrations in saliva determined by gas chromatography–mass spectrometry. Journal of Analytical Toxicology, 35, 148–152.
Adam, K. P., Ferrannini, E., Camastra, S., Natali, A., Nannipieri, M., & Mari, A. (2013). Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes, 62(5), 1730–1737. doi:10.2337/db12-0707.
Frazee, C. C., III, Garg, U., Kiscoan, M., Knoblauch, J., Scott, D., & Wasserman, G. (2007). Use of urine organic acids method for the analysis of gamma-hydroxybutricacid (GHB): Importance of urease in eliminating urea interference. Journal of Clinical Toxicology, 45, 194–196. doi:10.1080/15563650601006314.
Hur, H., Ham, I. H., Nguyen, D. T., Paik, M. J., Xuan, Y., Yun, J., et al. (2014). Quantitative measurement of organic acids in tissues from gastric cancer patients indicates increased glucose metabolism in gastric cancer. PLoS One, 9, e98581. doi:10.1371/journal.pone.0098581.
Kang, S., Chung, K. H., Oh, S. M., & Lee, S. (2014). A surrogate analyte-based LC–MS/MS method for the determination of γ-hydroxybutyrate (GHB) in human urine and variation of endogenous urinary concentrations of GHB. Journal of Pharmaceutical and Biomedical Analysis, 98, 193–200. doi:10.1016/j.jpba.2014.05.028.
Keating, G. M. (2014). Sodium oxybate: A review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence. Clinical Drug Investigation, 4(1), 63–80. doi:10.1007/s40261-013-0158-x.
Ahn, Y. H., Hong, S. K., Kim, J. W., Lee, G., Moon, S. M., & Park, M. J. (2010). Metabolomic screening and star pattern recognition by urinary amino acid profile analysis from bladder cancer patients. Metabolomics, 6, 202–206. doi:10.1007/s11306-010-0199-6.
Kuhara, T. (2005). Gas chromatographic–mass spectrometric urinary metabolome analysis to study mutations of inborn errors of metabolism. Mass Spectrometry Reviews, 24(6), 814–827. doi:10.1002/mas.20038.
Deakin, A., Levine, B., LeBeau, M. A., Montgomery, M. A., Morris-Kukoski, C., & Schaff, J. E. (2006). A comprehensive study on the variations in urinary concentrations of endogenous gamma-hydroxybutyrate (GHB). Journal of Analytical Toxicology, 30, 98–105.
Liebich, H. M. (1986). Gas chromatographic profiling of ketone bodies and organic acids in diabetes. Journal of Chromatogrphy B, 379, 347–366.
Maitre, M. (1997). The gamma-hydroxybutyrate signalling system in brain: Organization and functional implications. Progress in Neurobiology, 51, 337–361. doi:10.1016/S0301-0082(96)00064-0.
Paik, M. J., & Kim, K. R. (2004). Sequential ethoxycarbonylation, methoximation and tert-butyldimethylsilylation for simultaneous determination of amino acids and carboxylic acids by dual–column gas chromatography. Journal of Chromatogrphy A, 1034, 13–23.
Paik, M. J., Li, W. Y., Ahn, Y. H., Lee, P. H., Choi, S., Kim, K. R., et al. (2009). The free fatty acid metabolome in cerebral ischemia following human mesenchymal stem cell transplantation in rats. Clinica Chimica Acta, 402, 25–30. doi:10.1016/j.cca.2008.12.022.
Paik, M. J., Lee, H. J., & Kim, K. R. (2005). Simultaneous retention index analysis of urinary amino acids and carboxylic acids for graphic recognition of abnormal state. Journal of Chromatogrphy B, 821, 94–104. doi:10.1016/j.jchromb.2005.04.011.
Quang, L. S., Levy, H. L., & Law, T. (2005). Laboratory diagnosis of 1,4-BD and GHB overdose by routine urine organic acid analysis. Journal of Clinical Toxicology, 43, 321–323.
Robinson, D. M., & Keating, G. M. (2007). Sodium oxybate: A review of its use in the management of narcolepsy. CNS Drugs, 21(4), 337–354.
Seo, C., Hwang, Y. H., Kim, Y., Joo, B. S., Yee, S. T., Kim, C. M., et al. (2016). Metabolomic study of aging in mouse plasma by gas chromatography–mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 1025, 1–6. doi:10.1016/j.jchromb.2016.04.052.
Shim, W., Paik, M. J., Nguyen, D. T., Lee, J. K., Lee, Y., Kim, J. H., et al. (2012). Analysis of changes in gene expression and metabolic profiles induced by silica-coated magnetic nanoparticles. ACS Nano, 6(9), 7665–7680. doi:10.1021/nn301113f.
Struys, E. A., Salomons, G. S., Achouri, Y., van Schaftingen, E., Grosso, S., Craigen, W. J., et al. (2005). Mutations in the d-2-hydroxyglutarate dehydrogenasegene cause d-2-hydroxyglutaric aciduria. American Journal of Human Genetics, 76, 358–360. doi:10.1086/427890.
Struys, E. A., Verhoeven, N. M., Jansen, E. E. W., Ten Brink, H. J., Gupta, M., Burlingame, T. G., et al. (2006). Metabolism of γ-hydroxybutyrate to d-2-hydroxyglutarate in mammals: Further evidence for d-2-hydroxyglutarate transhydrogenase. Metabolism, 55, 353–358. doi:10.1016/j.metabol.2005.09.009.
van Amsterdam, J. G., Brunt, T. M., McMaster, M. T., & Niesink, R. J. (2012). Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose. Neuroscience and Biobehavioral Reviews, 36(4), 1217–1227. doi:10.1016/j.neubiorev.2012.02.002.
Waszkielewicz, A., & Bojarski, J. (2004). Gamma–hydrobutyric acid (GHB) and its chemical modifications: A review of the GHB ergic system. Polish Journal of Pharmacology, 56(1), 43–49.
Wong, C. G., Gibson, K. M., & Snead, O. C., 3rd. (2004). From the street to the brain: Neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends in Pharmacological Sciences, 25(1), 29–34. doi:10.1016/j.tips.2003.11.001.
Acknowledgements
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1A6A1A03011325), by the Ministry of Science, ICT & Future Planning (2015R1A4A1041219) and by Suncheon Research Center for Natural Medicines.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing financial interests.
Ethical approval
All procedures performed in studies involving animals were in accordance with the ethical standards of the National Forensic Service.
Rights and permissions
About this article
Cite this article
Seo, C., Park, M., Choi, B. et al. Metabolomic analysis of urinary organic acids following intraperitoneal injection with γ-hydroxybutyric acid in rats. Metabolomics 12, 190 (2016). https://doi.org/10.1007/s11306-016-1125-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11306-016-1125-3